Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121055273 | 12105527 | 3 | F | 2016 | 20160927 | 20160223 | 20160930 | EXP | BR-JNJFOC-20150905775 | JANSSEN | 0.00 | A | M | Y | 0.00000 | 20160930 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121055273 | 12105527 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | 0 | SOLUTION FOR INJECTION | ||||||||
| 121055273 | 12105527 | 2 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 121055273 | 12105527 | 3 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | U | 125261 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 121055273 | 12105527 | 4 | C | NATRIX | INDAPAMIDE | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 121055273 | 12105527 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 121055273 | 12105527 | 6 | C | SELOZOK | METOPROLOL SUCCINATE | 1 | Unknown | D | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121055273 | 12105527 | 1 | Psoriasis |
| 121055273 | 12105527 | 2 | Psoriasis |
| 121055273 | 12105527 | 3 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121055273 | 12105527 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121055273 | 12105527 | Calcium deficiency | |
| 121055273 | 12105527 | Decreased immune responsiveness | |
| 121055273 | 12105527 | Inappropriate schedule of drug administration | |
| 121055273 | 12105527 | Insomnia | |
| 121055273 | 12105527 | Off label use | |
| 121055273 | 12105527 | Psoriasis | |
| 121055273 | 12105527 | Tooth disorder | |
| 121055273 | 12105527 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121055273 | 12105527 | 2 | 20140507 | 0 | ||
| 121055273 | 12105527 | 3 | 201601 | 0 |